宫颈癌三级预防全周期数据集

1. 公共卫生政策制定与效果评估：基于覆盖疫苗接种、筛查到治疗的全周期数据，可系统评估区域宫颈癌防治策略的实际效果。例如分析HPV疫苗接种覆盖率与后期病变发生率的相关性，或比较不同筛查方案的卫生经济学效益，为政府优化防控资源配置与政策迭代提供实证依据。 2. 精准筛查与分层管理策略优化：整合HPV分型、细胞学及阴道镜等多模态数据，构建癌前病变风险预测模型。可帮助医疗机构识别高风险人群，制定个体化筛查间隔与随访方案，实现从“普遍筛查”到“精准分流”的转变，提升筛查效率并减少过度诊疗。 3. 临床诊疗决策支持与疗效研究：为不同阶段的宫颈癌患者（尤其关注保育治疗、复发管理等领域）提供结构化诊疗与预后数据。支持临床医生进行疗效对比与治疗方案优化，同时为后期开展真实世界研究、加速新产品评价提供高质量证据基础。 4. 疫苗与创新防治技术研发支持：提供从HPV感染到癌变的完整自然史数据链，助力疫苗企业评估长期保护效力、探索多价疫苗需求。同时可赋能AI早筛工具、自采样检测等创新技术的研发与验证，推动宫颈癌防治技术体系的迭代升级。

1. Public Health Policy Formulation and Effectiveness Evaluation: Based on full-cycle data covering vaccination, screening to treatment, this dataset can systematically assess the actual efficacy of regional cervical cancer prevention and control strategies. For instance, it can analyze the correlation between HPV vaccination coverage and the incidence of late-stage cervical lesions, or compare the health economic benefits of different screening protocols, providing empirical evidence for governments to optimize the allocation of prevention and control resources and iterate policies. 2. Precision Screening and Stratified Management Strategy Optimization: By integrating multi-modal data including HPV genotyping, cytology and colposcopy, this dataset constructs a precancerous lesion risk prediction model. It helps medical institutions identify high-risk populations, develop individualized screening intervals and follow-up plans, and realize the transformation from "universal screening" to "precision triage", thereby improving screening efficiency and reducing overdiagnosis and overtreatment. 3. Clinical Decision Support and Efficacy Research: This dataset provides structured diagnosis, treatment and prognosis data for cervical cancer patients at different stages, with particular focus on areas such as fertility-sparing treatment and recurrence management. It supports clinicians in conducting efficacy comparisons and optimizing treatment plans, while offering a high-quality evidence base for subsequent real-world studies and accelerated evaluation of new products. 4. Vaccine and Innovative Prevention and Control Technology R&D Support: It offers a complete natural history data chain from HPV infection to carcinogenesis, assisting vaccine enterprises in evaluating long-term protective efficacy and exploring the demand for multivalent vaccines. Meanwhile, it enables the R&D and validation of innovative technologies such as AI-based early screening tools and self-sampling tests, promoting the iterative upgrading of the cervical cancer prevention and control technology system.

搜集汇总

背景与挑战

背景概述

该数据集由重庆大学附属肿瘤医院构建，系统整合了从HPV疫苗接种、筛查、癌前病变管理到浸润癌诊疗及长期随访的全链条数据，遵循三级预防体系。它通过结构化整合流行病学、分子检测、临床诊疗等多维度信息，构建了覆盖疾病自然史与干预路径的纵向数据平台，旨在为公共卫生政策制定、筛查策略优化、临床诊疗规范建立以及疫苗与药物疗效评价提供高质量的真实世界证据。数据集以CSV格式提供，经过严格的脱敏与标准化处理，支持从群体预防到个体化管理的全周期科学决策。